HIK — Hikma Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- £3.11bn
- £4.17bn
- $3.35bn
UK's Hikma posts higher annual revenue on strong injectables segment
Hikma Pharmaceutical - Final Results, Share Buyback & Leadership Changes
UK Stocks-Factors to watch on February 26
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
UK's Hikma falls after Brookfield rules out buyout offer
UK Stocks-Factors to watch on February 5 (updated)
UK Stocks-Factors to watch on February 5
Brookfield rules out offer for UK's Hikma
Brookfield Pvt.Cap. Hikma Pharmaceutical - Statement regarding Hikma Pharmaceuticals Plc
Hikma Pharmaceutical - Notice of Results
Brief: Hikma Launches Enoby And Xtrenbo Referencing Prolia And Xgeva Respectively
US Supreme Court to hear 'skinny label' patent fight involving Amarin (updated)
US Supreme Court to hear 'skinny label' patent fight involving Amarin
Hikma slips after Barclays downgrades stock
Hikma Pharmaceutical - Director/PDMR Shareholding
Hikma Pharmaceutical - Director/PDMR Shareholding
Hikma Pharmaceutical - Director/PDMR Shareholding
Live Markets: Before the bell: Europe up, defence and weed stocks eyed